Business Context and Reporting Period
This Form 8-K is filed by Griffin-American Healthcare REIT IV, Inc. (referred to in the request as American Healthcare REIT, Inc.) on February 13, 2017. The report details material amendments to the company's Dealer Manager Agreement and the renewal of its Advisory Agreement.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it reports specific changes to fee structures and offering prices:
- Dealer Manager Fee: Reduced from 3.0% to 1.5% of gross offering proceeds for Class I common stock sales (effective March 1, 2017).
- Class I Offering Price: Reduced from $9.30 to $9.21 per share.
- Stockholder Servicing Fee: Continues to accrue daily at 1/365th of 1.0% of the purchase price of Class T shares (excluding DRIP shares).
- DRIP Purchase Price: Set at $9.40 per share for Class T and Class I shares until a net asset value is determined.
Material Changes Versus Prior Period
The primary material changes involve the reduction of costs associated with the initial public offering and the extension of the advisory relationship:
- Fee Reduction: The dealer manager fee for Class I shares was cut in half (from 3.0% to 1.5%), with the advisor funding the difference.
- Price Adjustment: The offering price for Class I shares was lowered by $0.09 per share to reflect the fee reduction.
- DRIP Pricing: The pricing mechanism for the Distribution Reinvestment Plan (DRIP) was adjusted from 95.0% of the primary offering price to a fixed $9.40 per share pending NAV determination.
- Advisory Term: The Advisory Agreement was renewed for an additional one-year term, now terminating on February 16, 2018.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, earnings outlook, or specific risk factors beyond the standard terms of the amended agreements. The renewal of the Advisory Agreement is contingent upon mutual written consent for any further extensions beyond February 16, 2018.
Investor Verification Checklist
- Verify the effective date of the fee reduction (March 1, 2017) and its impact on future capital raises.
- Confirm the current status of the Net Asset Value (NAV) determination for Class T shares to understand when the DRIP price will shift from the fixed $9.40.
- Review the full text of Exhibit 10.1 (Amendment No. 2) for any additional covenants or conditions not summarized in the 8-K.
- Monitor the February 16, 2018 deadline for the Advisory Agreement renewal.